These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 14985112)

  • 21. Discovery of loperamide as an antagonist of angiopoietin1 and angiopoietin2 by virtual screening.
    Gong XW; Mai JH; Xu YH
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2388-92. PubMed ID: 22406116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional inhibition of secreted angiopoietin: a novel role for angiopoietin 1 in coronary vessel patterning.
    Ward NL; Van Slyke P; Dumont DJ
    Biochem Biophys Res Commun; 2004 Oct; 323(3):937-46. PubMed ID: 15381091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyrosine phosphatase beta regulates angiopoietin-Tie2 signaling in human endothelial cells.
    Yacyshyn OK; Lai PF; Forse K; Teichert-Kuliszewska K; Jurasz P; Stewart DJ
    Angiogenesis; 2009; 12(1):25-33. PubMed ID: 19116766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
    Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
    Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of amino acid residues in PEPHC1 important for binding to the tumor-specific receptor EGFRvIII.
    Hansen CL; Hansen PR; Pedersen N; Poulsen HS; Gillings N; Kjaer A
    Chem Biol Drug Des; 2008 Oct; 72(4):273-8. PubMed ID: 18844673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiopoietin-1 overexpression modulates vascular endothelium to facilitate tumor cell dissemination and metastasis establishment.
    Holopainen T; Huang H; Chen C; Kim KE; Zhang L; Zhou F; Han W; Li C; Yu J; Wu J; Koh GY; Alitalo K; He Y
    Cancer Res; 2009 Jun; 69(11):4656-64. PubMed ID: 19487284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1.
    Simon MP; Tournaire R; Pouyssegur J
    J Cell Physiol; 2008 Dec; 217(3):809-18. PubMed ID: 18720385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-based design of an agonistic peptide targeting Fas.
    Yoshimori A; Takasawa R; Hayakawa A; Mizuno M; Yoshida J; Tanuma S
    Apoptosis; 2005 Mar; 10(2):323-9. PubMed ID: 15843893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabody.
    Popkov M; Jendreyko N; McGavern DB; Rader C; Barbas CF
    Cancer Res; 2005 Feb; 65(3):972-81. PubMed ID: 15705898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved tumor targeting by combined use of two antitenascin antibodies.
    Petronzelli F; Pelliccia A; Anastasi AM; D'Alessio V; Albertoni C; Rosi A; Leoni B; De Angelis C; Paganelli G; Palombo G; Dani M; Carminati P; De Santis R
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7137s-7145s. PubMed ID: 16203813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cooperatively Responsive Peptide Nanotherapeutic that Regulates Angiopoietin Receptor Tie2 Activity in Tumor Microenvironment To Prevent Breast Tumor Relapse after Chemotherapy.
    Zhang L; Qi Y; Min H; Ni C; Wang F; Wang B; Qin H; Zhang Y; Liu G; Qin Y; Duan X; Li F; Han X; Tao N; Zhang L; Qin Z; Zhao Y; Nie G
    ACS Nano; 2019 May; 13(5):5091-5102. PubMed ID: 30986342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening and identification of a peptide specifically targeted to NCI-H1299 from a phage display peptide library.
    Zang L; Shi L; Guo J; Pan Q; Wu W; Pan X; Wang J
    Cancer Lett; 2009 Aug; 281(1):64-70. PubMed ID: 19327883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The angiopoietin-TIE2 pathway is a potential therapeutic target in urothelial carcinoma.
    Jian W; Levitt JM; Lerner SP; Sonpavde G
    Anticancer Res; 2014 Jul; 34(7):3377-82. PubMed ID: 24982343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor-mediated gene delivery using polyethylenimine (PEI) coupled with polypeptides targeting FGF receptors on cells surface.
    Li D; Wang QQ; Tang GP; Huang HL; Shen FP; Li JZ; Yu H
    J Zhejiang Univ Sci B; 2006 Nov; 7(11):906-11. PubMed ID: 17048306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer.
    Szarvas T; Jäger T; Tötsch M; vom Dorp F; Kempkensteffen C; Kovalszky I; Romics I; Ergün S; Rübben H
    Clin Cancer Res; 2008 Dec; 14(24):8253-62. PubMed ID: 19088043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapamycin and cyclosporine have different effects on expression of Ang-1 and Ang-2 and Tie2 in rat renal allograft with chronic allograft nephropathy.
    Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP
    Transplant Proc; 2008 Oct; 40(8):2804-7. PubMed ID: 18929866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of Ang2 and Tie2 and their relation with the angiogenesis of hepatocellular carcinoma in rats].
    Li WZ; Yang P; Peng GC; Tang HH; Zhou J; Fu CY; Feng DY; Zhou X; Huang MP; Zhou GF
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):523-7. PubMed ID: 16951510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus.
    Kümpers P; David S; Haubitz M; Hellpap J; Horn R; Bröcker V; Schiffer M; Haller H; Witte T
    Ann Rheum Dis; 2009 Oct; 68(10):1638-43. PubMed ID: 18930996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer.
    Hata K; Nakayama K; Fujiwaki R; Katabuchi H; Okamura H; Miyazaki K
    Gynecol Oncol; 2004 Apr; 93(1):215-22. PubMed ID: 15047239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.